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Abstract
Background: Combinatorial biosynthesis techniques using
polyketide synthases (PKSs) in heterologous host organisms have
enabled the production of macrolide aglycone libraries in which
many positions of the macrolactone ring have been manipulated.
However, the deoxysugar moieties of macrolides, absent in
previous libraries, play a critical role in contributing to the
antimicrobial properties exhibited by compounds such as eryth-
romycin. Since the glycosidic components of polyketides drama-
tically alter their molecular binding properties, it would be useful
to develop general expression hosts and vectors for synthesis and
attachment of deoxysugars to expand the nature and size of such
polyketide libraries.
Results : A set of nine deoxysugar biosynthetic and auxiliary
genes from the picromycin/methymycin (pik) cluster was inte-
grated in the chromosome of Streptomyces lividans to create a host
which synthesizes TDP-D-desosamine. The pik desosaminyl
transferase was also included so that when the strain was
transformed with a previously constructed library of expression
plasmids encoding genetically modified PKSs that produce
different macrolactones, the resulting strains produced desosami-
nylated derivatives. Although conversion of the macrolactones
was generally low, bioassays revealed that, unlike their aglycone
precursors, these novel macrolides possessed antibiotic activity.
Conclusions: Based on the structural differences among the
compounds that were glycosylated it appears that the desosaminyl
transferase from the pik gene cluster is quite tolerant of changes in
the macrolactone substrate. Since others have demonstrated
tolerance towards modifications in the sugar substituent, one
can imagine employing this approach to alter both polyketide and
deoxysugar pathways to produce ‘unnatural’ natural product
libraries. ß 2001 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Polyketides are natural products that possess an array
of biological activities, ¢nding their way into many useful
clinical and agricultural applications. Much of the struc-
tural diversity and complexity among this class of com-
pounds can be attributed to the chemistry performed by
polyketide synthases (PKSs), large multifunctional en-
zymes that assemble the ‘core’ carbon systems of polyke-
tides from small organic acid precursors [1]. In fact, the
modular architecture of catalytic domains within PKSs
continues to be exploited by di¡erent rational and combi-
natorial engineering approaches to create further polyke-
tide diversity [2^4]. However, some of the structural vari-
ability among polyketides does not result from PKSs, but
rather is due to post-PKS biosynthetic steps which typi-
cally include oxidation and/or glycosylation by unique de-
oxy and amino sugars. Such modi¢cations are often nec-
essary to impart or enhance the speci¢c biological activity
of the molecule. For example, erythromycin A (Fig. 1)
contains two deoxysugar moieties, L-cladinose and D-des-
osamine, that are required for antibacterial activity and
the absence of either carbohydrate results in loss of po-
tency. Although some chemical modi¢cations to erythro-
mycin have been discovered which can ameliorate the loss
of the cladinose residue [5,6], there has been no substitu-
tion found for desosamine. This important deoxyaminosu-
gar is also present in other macrolide antibiotics such as
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oleandomycin and megalomicin, and is the only glycoside
necessary to confer antibacterial activity to picromycin,
methymycin, and the semisynthetic ketolide pharmaco-
phores (Fig. 1).
We and others recently described the production of
polyketide libraries generated by genetic modi¢cation of
macrolide PKSs in which enzymatic domains and entire
protein subunits were removed, added, or exchanged in
various combinations [3,4,7]. Since these libraries were
constructed in heterologous hosts lacking glycosylation
pathways, only the corresponding aglycones were pro-
duced. We wished to expand the capabilities of the com-
binatorial biosynthesis strategies described in the previous
work to incorporate post-PKS tailoring steps, in particular
the addition of deoxysugar components. Some experi-
ments have been performed in which structurally modi¢ed
macrolactones are subsequently glycosylated in their na-
tive hosts [8^12], and also in bioconversion experiments in
which a modi¢ed aglycone is fed to a PKS-blocked mutant
strain [13]. These experiments indicate that glycosyltrans-
ferases are able to accept polyketide substrates with some
amount of structural alteration. However, neither of these
approaches is well-suited for the production and biological
screening of large numbers of compounds since most
polyketide host organisms are di⁄cult to genetically ma-
nipulate and the bioconversion of aglycones requires a
tedious initial puri¢cation step. A more practical approach
is the heterologous expression of deoxysugar biosynthetic
pathways in hosts which have been developed for library
expression. Although the e¡ort to clone entire deoxysugar
biosynthetic pathways in a heterologous organism can be
a signi¢cant initial investment (most deoxysugars require
six or more enzymatic steps whose genes are typically
scattered within a polyketide gene cluster), these expres-
sion vectors, once made, can be easily combined with
those containing PKSs to rapidly engineer glycosylated
libraries. Olano et al. recently utilized a two plasmid sys-
tem to produce L-daunosamine, the deoxyaminosugar of
daunorubicin and doxorubicin, in Streptomyces lividans
[14].
Here we report the development of a single expression
vector for the production of desosaminylated macrolides
in Streptomyces. Desosamine was selected as the sugar
constituent because, based on the structures in Fig. 1, it
was believed that addition of this single deoxysugar would
be su⁄cient to confer antibacterial activity upon macro-
lactones to which it was attached. The expression vector
was combined with a library of existing PKS expression
plasmids to produce several novel glycosylated macrolide
compounds in S. lividans, providing the ¢rst examples in
which both polyketide and deoxysugar pathways have
been placed in a single heterologous host.
2. Results
2.1. Construction and validation of a desosamine expression
system
The picromycin/methymycin (pik) gene cluster from
Streptomyces venezuelae [15] was chosen as the source of
desosamine biosynthetic genes rather than other available
clusters (i.e. erythromycin, oleandomycin, or megalomicin)
for several reasons. First, all of the genes required for
biosynthesis of TDP-D-desosamine from glucose-1-phos-
phate (Fig. 2), a primary metabolite, as well as the desos-
aminyl transferase are present in the pik cluster whereas
one or more of the genes are missing or not yet identi¢ed
in each of the other clusters. Second, the genes from the
pik cluster are comprised in a single contiguous segment of
DNA (the des cluster), compared to those in other clusters
which are dispersed among other genes, facilitating clon-
ing and plasmid construction. Third, the natural substrates
for the desosaminyl transferase from the pik gene cluster,
narbonolide (1) and 10-deoxymethynolide (2), are them-
selves aglycones; in each of the other cases desosamine
is attached subsequent to addition of at least one other
sugar. Furthermore, the di¡erence in macrolactone ring
sizes between narbonolide (1) and 10-deoxymethynolide
(2) (14 and 12 atoms, respectively) suggests that the desos-
aminyl transferase from this cluster is somewhat forgiving
towards its polyketide substrate.
Seven genes in the des cluster, desI, desII, desIII, desIV,
desV, desVI, and desVIII, are presumed to be responsible
for the biosynthesis of TDP-D-desosamine (Fig. 2) [16].
Also present is the desVII gene encoding the glycosyltrans-
ferase. In addition to catalyzing the transfer of desosamine
to both 12- and 14-membered macrolactones, it has been
Fig. 1. Desosamine (blue) containing antibiotics. Erythromycin, oleando-
mycin, and picromycin are naturally occurring polyketide antibiotics.
Telithromycin (HMR 3647) is a potent semisynthetic derivative of eryth-
romycin currently in clinical trials.
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shown that DesVII is able to incorporate non-natural de-
oxysugar substrates [16,17]. The desR gene encodes a
L-glucosidase that removes a glucose residue attached to
the C-2P hydroxyl of desosamine [18]. It is believed that
the glucosylation of desosamine containing macrolides like
methymycin, picromycin, and oleandomycin, causes inac-
tivation and provides self-resistance to these compounds
which are reactivated by a L-glucosidase upon export
Fig. 2. (a) Enzymes from the des cluster of S. venezuelae involved in biosynthesis of TDP-D-desosamine and attachment to narbonolide (1) and 10-
deoxymethynolide (2) and (b) construction of an expression vector using the corresponding genes. See text for details.
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[18,19]. S. lividans is known to possess at least two such
glucosyltransferases which inactivate erythromycin and
picromycin by the same mechanism [20] (R. McDaniel,
unpublished observations). Therefore, it was important
to include this gene for expression in S. lividans in order
to produce desosaminylated compounds without the glu-
cose modi¢cation.
The expression system used here was adopted from the
multi-vector system developed for separate expression of
erythromycin PKS, or 6-deoxyerythronolide B (6-dEB)
synthase (DEBS), subunits in Streptomyces [4,21]. Plasmid
pKOS39-104 (Fig. 2) contains the des genes cloned in a
single orientation under control of the actI promoter and
actII-4 activator. Since pKOS39-104 is a derivative of
pSET152 [22], it contains the PC31-int-attP loci for chro-
mosomal integration in Streptomyces and can be used in
conjunction with our pRM5-based PKS expression plas-
mid library [3]. S. lividans K4-114 was transformed with
pKOS39-104 and designated K39-22. Con¢rmation that
this strain produced TDP-D-desosamine was performed
by feeding aglycones to the strain and looking for the
presence of desosaminylated compounds by LC/MS anal-
ysis.
Four aglycones (V10 mg/l each) were fed to liquid fer-
mentations of S. lividans K39-22: narbonolide (1) and 10-
deoxymethynolide (2), the natural substrates for DesVII,
3-keto-6-dEB (5), and 6-dEB (6) (Fig. 3). Fermentation
broth from all four aglycone-fed strains displayed antibac-
terial activity against Bacillus subtilis whereas S. lividans
K39-22 alone produced no detectable activity. LC/MS
analysis was consistent with the conversion of each of
the aglycones to their corresponding desosaminylated de-
rivatives, narbomycin (3), 10-deoxymethymycin (YC17, 4),
3-keto-5-O-desosaminyl-6-dEB (7), and 5-O-desosaminyl-
6-dEB (8) (Fig. 3), although a signi¢cant amount (V50^
90%) of the aglycone remained unconverted in each of the
samples. In each case, the parent ion (M+H) of the ex-
pected compound was detected in addition to a character-
istic ion at 158 amu which is produced by the desosamine
glycoside under the ionization conditions used. In the case
of the narbonolide-fed strain, the compound produced was
compared to authentic narbomycin obtained from Strep-
tomyces narbonensis. For each of the other compounds,
the location and/or stereochemistry of desosamine attach-
ment is inferred from the natural substrate speci¢city of
DesVII.
These results established that our des expression vector
was functional and that the DesVII glycosyltransferase
was able to glycosylate non-natural macrolactone sub-
strates. The bioassay results also con¢rmed our prediction
that desosamine is su⁄cient to confer antibacterial activity
to these macrolactones. There were no 2P-O-glucosyl de-
rivatives detected which implies the DesR glucosidase in-
cluded in pKOS39-104 was also operational, although mi-
nor glucosylated products were putatively found in
subsequent experiments with the strain (see below).
2.2. Co-expression of desosamine and aglycone pathways in
S. lividans
Although expression of both a modular polyketide
pathway and a deoxysugar pathway together in a heterol-
ogous host has not been reported, the bioconversion re-
sults suggested that transformation of S. lividans K39-22
with plasmids encoding macrolide PKSs would lead to
production of desosaminylated compounds. We intro-
duced plasmids harboring the PKSs which, in S. lividans,
produce the same four aglycones used in the above bio-
conversion studies. Plasmid pKOS39-86 contains the pic-
romycin/methymycin PKS and produces both narbonolide
(1) and 10-deoxymethynolide (2) [23]. Plasmid pKAO127
contains DEBS and produces 6-dEB (6) [24]. Plasmid
pKOS39-18 contains DEBS with a modi¢ed terminal
module that produces 3-keto-6-dEB (5) [23].
Culture broth from each of the transformed strains dis-
played activity against B. subtilis (Fig. 4). LC/MS analysis
was performed as above and in each case a new compound
with mass corresponding to the predicted desosaminylated
polyketide (Fig. 5) was identi¢ed. Since these are the same
compounds as those produced in the bioconversion experi-
ments, we again infer the regiochemical and stereochemi-
cal con¢gurations of desosamine attachment as above.
The aglycone precursors produced by the PKS in each
Fig. 3. Bioconversion of aglycones by S. lividans K39-22. S. lividans
K39-22 contains the desosamine expression vector shown in Fig. 2b.
Conversion of each aglycone to a desosaminylated derivative was con-
¢rmed by LC/MS. Compounds 3 and 4 are the natural products of the
desosaminyltransferase, DesVII, expressed in this strain. Aglycones 5
and 6 are novel substrates for DesVII and the assignment of desosamine
attachment to C-5 and its stereochemical con¢guration in compounds 7
and 8 is based on the natural speci¢city of the enzyme.
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strain were also present as well as putative 2P-O-glucosyl
derivatives of the desosaminylated macrolides. The total
yield of narbomycin and 10-deoxymethymycin in S. livid-
ans K39-22/pKOS39-86 was approximately 1 mg/l each
and represents about a 20% conversion of the total agly-
cone produced. Thus, although both PKS and deoxysugar
pathways function as expected, complete glycosylation of
even the natural substrates for DesVII did not occur.
S. lividans K39-22 contains a copy of the ermE macrolide
resistance gene and no obvious growth defects were ob-
served with production of the biologically active com-
pounds. These results suggest that a limiting amount of
TDP-D-desosamine is being produced by the strain (see
Section 3).
2.3. Production and biological screening of a glycosylated
macrolide library
Over 50 PKS expression plasmids have been constructed
and tested in our laboratory using DEBS and other mac-
rolide PKS genes [3,7,23]. These PKSs produce a variety
of 14 membered macrolactones in which single or multiple
carbon centers have been altered. Each plasmid contains
the same pRM5-based vector as above, providing a con-
venient opportunity to expand and diversify our existing
aglycone library by routine transformation of S. lividans
K39-22. Since a C-5 hydroxyl would be necessary for gly-
cosylation we chose to test a subset of 19 additional plas-
mids encoding PKSs that produce compounds containing
this functional group. Furthermore, the desired polyketi-
des would theoretically possess antibiotic activity and the
transformed strains could therefore be readily analyzed in
a simple bioassay for production of glycosylated macro-
lides.
All of the strains transformed and tested displayed anti-
microbial activity against B. subtilis (Fig. 4). The hypo-
thetical bioactive compounds are shown in Fig. 5. These
structures are deduced from the known aglycones pro-
duced by the PKSs and the presumed regiospeci¢city
and stereospeci¢city of the DesVII glycosyltransferase.
The presence of desosamine on polyketides from six of
these strains was veri¢ed by LC/MS analysis. The parent
ion of the predicted desosaminylated compound(s) was
observed along with the 158 amu desosamine fragment
in each of the strains containing plasmids pKOS24-15,
pKOS11-62, pKOS15-30, pKOS15-22, pKOS15-106, and
pKOS39-20 (Fig. 5). In two of these strains (pKOS11-62
and pKOS15-106), more than one putative desosamine
containing compound was detected. In S. lividans K39-
22/pKOS15-106, compounds with masses corresponding
to both 3-hydroxy and 3-keto derivatives were observed
(Fig. 5). This is consistent with the production of both
aglycones by plasmid pKOS15-106 alone in S. lividans
(R. McDaniel, unpublished observations). Two com-
pounds were also detected in the strain with pKOS11-62,
one of molecular weight consistent with the predicted mol-
ecule, 5-O-desosaminyl-10-desmethyl-6-dEB, and a puta-
tive dehydrated derivative at carbons C-10 and C-11
(Fig. 5). Both aglycones were also identi¢ed when the
plasmid was originally analyzed in S. lividans K4-114 [3],
although only the former was reported at that time. As
with the ¢rst set of plasmids tested, small amounts of
2P-O-glucosylated derivatives could also be detected in
some of the culture extracts. The yields of the desosamine
Fig. 4. Biological screening of strains containing engineered desosamine and polyketide biosynthetic pathways. The text below each spot indicates the
name of the plasmid used to transform S. lividans K39-22. Each plasmid encodes a distinct engineered PKS that produces one or more macrolactones
which do not possess antibacterial activity. In the background of S. lividans K39-22, inhibition of B. subtilis growth can be observed, indicating that a
desosaminylated compound(s) is being produced. The inferred corresponding structures are shown in Fig. 5. The size of zone clearing is not indicative
of potency since the titers of compound vary for each strain.
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Fig. 5. Putative structures of bioactive compounds in Fig. 4. The PKSs encoded on plasmids pKOS39-86, pKAO127‘kan’, and pKOS39-18 are described
in the text. The remaining plasmids encode DEBS with one or more modi¢cations that produce derivatives of 6-dEB (6) (changes in 6-dEB structure
are shown in red) [3]. The presence of those compounds above the line are supported by LC/MS analysis while those below the line are hypothetical
and assumed to be present based on the antibacterial activity detected and the known structure of the aglycone produced. The regiochemistry and ster-
eochemistry of desosamine attachment is assigned according to the natural speci¢city of the DesVII enzyme.
CHBIOL 97 5-6-01 Cyaan Magenta Geel Zwart
552 Chemistry & Biology 8/6 (2001) 547^555
containing compounds were too low to determine absolute
titers (6 1 mg/l) and, therefore, the relative antibacterial
activity of the compounds could not be determined from
these assays.
3. Discussion
We have demonstrated a minimal set of seven genes
(desI, II, III, IV, V, VI, VIII) is su⁄cient for biosynthesis
of TDP-desosamine from glucose-1-phosphate in S. livid-
ans. The apparent low abundance of TDP-desosamine in
the engineered host could be due either to the availability
of glucose-1-phosphate in this host or to poor expression
of the sugar biosynthesis and/or transferase genes. Alter-
natively, it is interesting to note that narbonolide and 10-
deoxymethynolide are present in the natural picromycin/
methymycin producing organism, S. venezuelae, and could
therefore re£ect that one or more of the enzymes from the
des cluster is relatively ine⁄cient. It may be possible,
therefore, to improve the amount of TDP-D-desosamine
either by increasing expression levels of these genes and/
or by complementing one or more of the enzymes in the
pathway with homologs from other clusters such as eryth-
romycin or oleandomycin.
Expression of the minimal desosamine biosynthesis
genes together with the DesVII desosaminyltransferase in
S. lividans has enabled the production of more than 20
glycosylated macrolides with detectable antibacterial activ-
ity. The structures of the macrolides that were glycosylated
highlight both the remarkable substrate tolerance of the
DesVII glycosyltransferase as well as the ability of desos-
amine to impart biological activity to structurally diverse
macrolactones. In addition to their antibacterial properties
the desosamine containing compounds presented here may
possess additional biological properties that are associated
with erythromycin and other macrolides, including motilin
receptor antagonism and anti-in£ammatory activities. Fur-
thermore, the demonstration by others that DesVII and
other glycosyltransferases can also tolerate modi¢cations
of the sugar substituent [16,17,25] opens the door to ma-
nipulation of both polyketide and deoxysugar pathways
for the production of ‘unnatural’ natural product libraries.
4. Signi¢cance
Desosamine is an important deoxyaminosugar present
on a number of structurally related macrolide antibiotics
such as erythromycin and is the only glycoside present on
picromycin, methymycin, and the highly potent semisyn-
thetic ketolides. The desosamine biosynthetic genes from
the picromycin/methymycin (pik) cluster of S. venezuelae
were integrated in the chromosome of S. lividans to create
a host which synthesizes TDP-D-desosamine and can be
used in combination with PKS expression plasmids to gen-
erate libraries of desosaminylated polyketides. We demon-
strate the versatility of the DesVII desosaminyltransferase
by creating desosaminylated macrolides from more than
20 di¡erent 14-membered lactones. The attachment of
desosamine is su⁄cient to confer antibiotic activity to
each of the otherwise inactive aglycones and reinforces
the notion that this sugar plays a critical role in the
molecular binding properties of erythromycin and related
macrolides. This host and others which might be en-
gineered to produce deoxysugar and polyketide tailoring
pathways are valuable tools for expanding the size and
diversity of polyketides that can be generated by combi-
natorial biosynthesis.
5. Materials and methods
5.1. Strains, culture conditions, and DNA manipulation
DNA manipulation was performed in Escherichia coli XL1-
Blue (Stratagene) using standard protocols [26]. B. subtilis was
grown in LB at 37‡C. PCR was performed with Pfu polymerase
(Stratagene) under conditions recommended by the manufacturer.
S. lividans K4-114 [24] was used as the host for expression of
engineered PKS and desosamine genes. S. lividans strains were
maintained on R2YE agar plates [27] with appropriate antibiotic
selection. S. lividans protoplasts were transformed by the stan-
dard procedure [27] and transformants were selected using 1 ml
of a 1 mg/ml thiostrepton and/or 1 ml of a 2 mg/ml apramycin
overlay on R2YE regeneration plates.
5.2. Construction of expression plasmids
Expression plasmid pKOS39-104 was constructed as follows.
The 6.0 kb BglII^PstI fragment containing the picromycin des-
VIII, desVII, desVI and desR (partial) genes from cosmid
pKOS23-26 [28] was subcloned into the BglII^PstI sites of
pKOS39-98, a pUC19 derivative with a redesigned multiple clon-
ing site. The resulting plasmid, pKOS39-100, contains a PacI site
upstream of the BglII site which is used in a later cloning step.
The 6 kb SphI^PstI fragment containing the desI (partial), desII,
desIII, desIV and desV genes from pKOS23-26 was subcloned
into the SphI^PstI of pUC19 to make pKOS39-102. The remain-
ing 3P-end of the desR gene and 5P-end of the desI gene were PCR
ampli¢ed from cosmid pKOS23-26 with the following oligo-





The two PCR fragments were digested with NsiI^XbaI and
XbaI^EcoRI, respectively, and ligated with NsiI^EcoRI-digested
Litmus 28 (New England Biolabs) to obtain pKOS39-101B. The
6 kb SphI^EcoRI fragment of pKOS39-102 was inserted into
pKOS39-101B to make pKOS39-103. The 6.4 kb NsiI^EcoRI
fragment of pKOS39-103 and the 6 kb PacI^PstI fragment of
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pKOS39-100 were then ligated together with the 8.5 kb PacI^
EcoRI fragment of pKOS39-44 [23], yielding the ¢nal expression
plasmid pKOS39-104 (Fig. 2b).
5.3. Production and analysis of compounds
All strains were grown in 5 ml liquid R2YE medium at 30‡C
and analyzed following 5 days growth. For bioconversion experi-
ments, aglycones (V10 mg/l) were fed at the start of fermenta-
tion. Fermentation broth was analyzed directly by liquid chro-
matography/mass spectrometry (LC/MS) and evaporative light
scattering detection (ELSD) as previously described [23]. An au-
thentic sample of narbomycin prepared from S. narbonensis [28]
was used to validate production of this compound. For LC/MS
analysis of strains containing PKS expression plasmids the cul-
tures were extracted twice with 5 ml of ethyl acetate/triethylamine
(99:1), evaporated to dryness and resuspended in 0.5 ml of ace-
tonitrile.
5.4. Antibacterial assays
Extracts prepared from the culture broths as above were as-
sayed for biological activity against B. subtilis using an agar plate
di¡usion method. Samples (5 Wl) from each of the extracts were
pipetted to sterile ¢lter disks, dried, and placed on an LB plate
spread with 20 Wl of an overnight culture of B. subtilis. The plates
were incubated overnight at 37‡C to visualize zones of growth
inhibition.
Acknowledgements
We thank John Carney for assistance with compound
analysis, C.R. Hutchinson, Leonard Katz, Chaitan Kho-
sla, and Daniel Santi for helpful comments on the manu-
script.
References
[1] D. O’Hagan (1991) The polyketide metabolites, Ellis Horwood, Chi-
chester.
[2] C.R. Hutchinson, Combinatorial Biosynthesis for new drug discov-
ery, Curr. Opin. Microbiol. 1 (1998) 319^329.
[3] R. McDaniel, A. Thamchaipenet, C. Gustafsson, H. Fu, M. Betlach,
M. Betlach, G. Ashley, Multiple genetic modi¢cations of the eryth-
romycin gene cluster to produce a library of novel ‘unnatural’ natural
products, Proc. Natl. Acad. Sci. USA 96 (1999) 1846^1851.
[4] Q. Xue, G. Ashley, C.R. Hutchinson, D.V. Santi, A multi-plasmid
approach to preparing large libraries of polyketides, Proc. Natl.
Acad. Sci. USA 96 (1999) 11740^11745.
[5] G. Griesgraber, Y.T. Or, D.T.W. Chu, A.M. Nilius, P.M. Johnson,
R.K. Flamm, R.F. Henry, J.J. Plattner, 3-Keto-11,12-carbazate de-
rivatives of 6-O-methylerythromycin A: Synthesis and in-vitro activ-
ity, J. Antibiot. 49 (1996) 465^477.
[6] C. Agouridas, A. Denis, J.-M. Auger, Y. Benedetti, A. Bonnefoy, F.
Bretin, J.-F. Chantot, A. Dussarat, C. Fromentin, S.G. D’Ambriere's,
S. Lachaud, P. Laurin, O. Le Martret, V. Loyau, N. Tessot, Synthesis
and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin
derivatives): A new class of antibacterials highly potent against mac-
rolide-resistant and -susceptible respiratory pathogens, J. Med.
Chem. 41 (1998) 4080^4100.
[7] L. Tang, H. Fu, R. McDaniel, Formation of functional heterologous
complexes using subunits from the picromycin, erythromycin, and
oleandomycin polyketide synthases, Chem. Biol. 7 (2000) 77^84.
[8] S. Donadio, M.J. Staver, J.B. McAlpine, S.J. Swanson, L. Katz,
Modular organization of genes required for complex polyketide bio-
synthesis, Science 252 (1991) 675^679.
[9] S. Donadio, J.B. McAlpine, P.J. Sheldon, M. Jackson, L. Katz, An
erythromycin analog produced by reprogramming of polyketide syn-
thesis, Proc. Natl. Acad. Sci. USA 90 (1993) 7119^7123.
[10] X.R. Ruan, A. Pereda, D.L. Stassi, D. Zeidner, R.G. Summers, M.
Jackson, A. Shivakumar, S. Kakavas, M.J. Staver, S. Donadio, L.
Katz, Acyltransferase domain substitutions in erythromycin polyke-
tide synthase yields novel erythromycin derivatives, J. Bacteriol. 179
(1997) 6416^6425.
[11] D.L. Stassi, S.J. Kakavas, K.A. Reynolds, G. Gunawardana, S.
Swanson, D. Zeidner, M. Jackson, H. Liu, A. Buko, L. Katz, Eth-
yl-substituted erythromycin derivatives produced by directed meta-
bolic engineering, Proc. Natl. Acad. Sci. USA 95 (1998) 7305^
7309.
[12] A.F.A. Marsden, B. Wilkinson, J. Corte¤s, N.J. Dunster, J. Staunton,
P.F. Leadlay, Engineering broader speci¢city into an antibiotic-pro-
ducing polyketide synthase, Science 279 (1998) 199^202.
[13] J.R. Jacobsen, C.R. Hutchinson, D.E. Cane, C. Khosla, Precursor-
directed biosynthesis of erythromycin analogs by an engineered poly-
ketide synthase, Science 277 (1997) 367^369.
[14] C. Olano, N. Lomovskaya, L. Fonstein, J.T. Roll, C.R. Hutchinson,
A two-plasmid system for the glycosylation of polyketide antibiotics:
bioconversion of O-rhodomycinone to rhodomycin D, Chem. Biol. 6
(1999) 845^855.
[15] Y. Xue, L. Zhao, H.-w. Liu, D.H. Sherman, A gene cluster for the
macrolide antibiotic biosynthesis in Streptomyces venezuelae : Archi-
tecture of metabolic diversity, Proc. Natl. Acad. Sci. USA 95 (1998)
12111^12116.
[16] L. Zhao, D.H. Sherman, H.-w. Liu, Biosynthesis of desosamine:
construction of a new methymycin/neomethymycin analogue by dele-
tion of a desosamine biosynthetic gene, J. Am. Chem. Soc. 120 (1998)
10256^10257.
[17] L. Zhao, J. Ahlert, Y. Xue, J.S. Thorson, D.H. Sherman, H.-w. Liu,
Engineering a methymycin/pikromycin-calicheamicin hybrid: con-
struction of two new macrolides carrying a designed sugar moiety,
J. Am. Chem. Soc. 121 (1999) 9881^9882.
[18] L. Zhao, D.H. Sherman, H.-w. Liu, Biosynthesis of desosamine:
molecular evidence suggesting L-glucosylation as a self-resistance
mechanism in methymycin/neomethymycin producing strain, Strepto-
myces venezuelae, J. Am. Chem. Soc. 120 (1998) 9374^9375.
[19] L.M. Quiros, I. Aguirrezabalaga, C. Olano, C. Mendez, J.A. Salas,
Two glycosyltransferases and a glycosidase are involved in oleando-
mycin modi¢cation during its biosynthesis by Streptomyces antibioti-
cus, Mol. Microbiol. 28 (1998) 1177^1185.
[20] G. Jenkins, E. Cundli¡e, Cloning and characterization of two genes
from Streptomyces lividans that confer inducible resistance to linco-
mycin and macrolide antibiotics, Gene 108 (1991) 55^62.
[21] R. Ziermann, M. Betlach, A two-vector system for the production of
recombinant polyketides in Streptomyces, J. Ind. Microbiol. Biotech-
nol. 24 (2000) 46^50.
[22] M. Bierman, R. Logan, K. O’Brien, E.T. Seno, R. Nagaraja, B.E.
Schoner, Plasmid cloning vectors for the conjugal transfer of DNA
from Escherichia coli to Streptomyces spp, Gene 116 (1992) 43^49.
[23] L. Tang, H. Fu, M.C. Betlach, R. McDaniel, Elucidating the mech-
anism of chain termination switching in the picromycin/methymycin
polyketide synthase, Chem. Biol. 6 (1999) 553^558.
[24] R. Ziermann, M.C. Betlach, Recombinant polyketide synthesis in
Streptomyces : Engineering of improved host strains, Biotechniques
26 (1999) 106^110.
CHBIOL 97 5-6-01 Cyaan Magenta Geel Zwart
554 Chemistry & Biology 8/6 (2001) 547^555
[25] S. Gaisser, J. Reather, G. Wirtz, L. Kellenberger, J. Staunton, P.F.
Leadlay, A de¢ned system for hybrid macrolide biosynthesis in Sac-
charopolyspora erythraea, Mol. Microbiol. 36 (2000) 391^401.
[26] J. Sambrook, E.F. Fritsch, T. Maniatis (1989) Molecular Cloning: A
Laboratory Manual, Cold Spring Harbor Laboratory Press, Plain-
view, NY.
[27] D.A. Hopwood, M.J. Bibb, K.F. Chater, T. Kieser, C.J. Bruton,
H.M. Kieser, D.J. Lydiate, C.P. Smith, J.M. Ward, H. Schrempf
(1985) Genetic Manipulation of Streptomyces : A Laboratory Man-
ual, The John Innes Foundation, Norwich.
[28] M.C. Betlach, J.T. Kealey, M.C. Betlach, G.A. Ashley, R. McDaniel,
Characterization of the macrolide P-450 hydroxylase from Strepto-
myces venezuelae which converts narbomycin to picromycin, Bio-
chemistry 37 (1998) 14937^14942.
CHBIOL 97 5-6-01 Cyaan Magenta Geel Zwart
Research Paper Desosamine containing polyketide libraries L. Tang, R. McDaniel 555
